P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
RYTM | N/A | N/A | N/A | +53.78% |
RYTM Peer | N/A | N/A | N/A | +28.91% |
Biotechnology Industry | 18.4 | 17.1 | 0.4 | +643.73% |
Health Technology Sector | 31.8 | 20.9 | 0.6 | +119.23% |
S&P 500 Market | 31.2 | 30.9 | 1.0 | +100.97% |
Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
---|---|---|---|---|
Mean Estimate | -$1.05 | -$1.00 | -$1.03 | -$0.69 |
Previous Mean | -$1.00 | -$1.00 | N/A | N/A |
Standard Deviation | 0.07 | 0.14 | 0.26 | N/A |
Low Estimate | -$1.11 | -$1.14 | -$1.59 | -$0.69 |
High Estimate | -$0.89 | -$0.71 | -$0.70 | -$0.69 |